Skin Longevity: Taking Care of Your Skin for the Long Run Learn more
Autologous Micrografting for Hair Loss is a non-surgical regenerative technology that utilises the body’s regenerative ability and micrografts to enhance hair growth. In this, a hair serum of growth factors and progenitor cells is extracted using small samples of skin from one’s scalp and then introduced back to the balding areas of the scalp.

This treatment is suitable for individuals experiencing mild to moderate hair loss related to hormonal changes, such as male and female pattern hair loss (also known as androgenetic alopecia), or associated with ageing and/or stress.
Autologous Micrografting Technology (AMT) is not meant to replace hair transplant surgery, which is used to treat severe hair loss and to advance any receding hairlines.
Realistically, instead of achieving a full crown, AMT helps to maintain and boost the hairs you already have for improved scalp coverage (i.e., see less white of the scalp).
In contrast to traditional hair transplants, the downtime from Autologous Micrograft Technology is close to none.
It’s a Spanish technology and has been approved for use in over 60 countries since 2014.
This includes US FDA and European CE clearance.
All it takes is normal saline water and your own skin cells. No risk of rejection or allergy.
Androgenetic alopecia, which is hair loss due to ageing and hormones, is the most common cause of hair loss. Yet, this form of hair loss has limited treatment options that can restore the crown to how it was.
To date, in addition to AMT, there are topicals (minoxidil lotion or foam), orals (finasteride), hair microneedling (available as home kits or professional-grade services), hair lasers and a whole array of over-the-counter hair supplements.
Each of these treatments addresses a different pathway of hair loss and works to varying degrees. When AMT for hair loss is combined with at least an oral or topical treatment, or better still, an oral or topical treatment and a professional treatment like hair microneedling, the hair-restoring effect can be multiplied.
Everyone experiences hair loss differently, so treatment plans are tailored to individual needs.
The scalp is carefully assessed to determine appropriate injection points based on clinical evaluation.
Clinical studies have demonstrated that hair growth (density and thickness) can be appreciated from the first month of treatment, with improvements continuing up to 6 months, and effects can last for at least a year.
Only a small square of hair is neatly shaved (about 1 cm by 1 cm), sited inconspicuously behind the ear. This small patch can be well concealed for those with longer hair, and for those with short hair, this is hardly noticeable by others.
Unlike hair transplants, shaving down the balding areas is also unnecessary.
The injection process (~20 minutes) is tolerable, consisting of tiny pinpricks likened to a scalp acupuncture treatment.
Any discomfort is kept to a minimum with local and topical anaesthesia.
From preparation to the procedure to exit.
The light and dry dressing is kept overnight and removed the next day.
Aside from avoiding hair chemicals for 2 weeks (such as pool or sea water, and hair treatments like colouring and perming), no drastic lifestyle changes are required.
Typical look when the bandage is taken out the next day.
3 small and dry wounds that will heal over 2 weeks. Hair has been noted to regrow over this area, so overall no net hair loss, but only more to gain!

Typical patients who see us are those in their 30s to 50s, seeking a preventative approach.
At IYAC, our doctors provide a medical diagnosis with our AI-powered trichoscopy analysis and have curated a broad range of scientifically backed hair treatments and products to promote your scalp health and hair quality.
If you are experiencing any hair woes, ask us for help and experience the IYAC difference.
References:
1. Ruiz RG, Rosell JMC, Ceccarelli G, De Sio C, De Angelis GC, Pinto H, Astarita C, Graziano A. Progenitor-cell-enriched micrografts as a novel option for the management of androgenetic alopecia. J Cell Physiol. 2020 May;235(5):4587-4593. doi: 10.1002/jcp.29335. Epub 2019 Oct 23. PMID: 31643084.
2. Gentile P. Autologous Cellular Method Using Micrografts of Human Adipose Tissue Derived Follicle Stem Cells in Androgenic Alopecia. Int J Mol Sci. 2019 Jul 13;20(14):3446. doi: 10.3390/ijms20143446. PMID: 31337037; PMCID: PMC6678214.